Botfet / Company detail

TAK

rejected

Takeda Pharmaceutical Company Limited

biotech

Moat scoreNot available: not scored quality failout of 100

Rejectionquality_fail

The numbers

Financial metrics

Quality gate and thesis context

Roic3.1%

Gross Margin51.1%

Revenue Cagr7.6%

Fcf Conversion308.3%

Fcf YieldNot available: currency mismatch

Interest Coverage3.6x

Market Cap B$64.9B

Pe55.9

Quality PassFail

Founder LedNo

Thesis AlignedYes

Moat QuantNot available: not scored quality fail

Why it may endure

Quant: · Curator:

Market Share StabilityNot available: not scored quality fail

Network EffectsNot available: not scored quality fail

Pricing PowerNot available: not scored quality fail

Regulatory MoatNot available: not scored quality fail

Switching CostsNot available: not scored quality fail

ConvictionNot available: not scored quality fail

LeadershipNot available: not scored quality fail

VisionNot available: not scored quality fail